300255.SZ
常山药业
SZSE · Healthcare · C 制造业 · CN
CNY 23.38
−4.69%Margins
Gross margin
15.5%
EBITDA margin
-32.2%
EBIT margin
-39.9%
Net margin
-40.8%
FCF margin
-17.3%
-29.4%
Return on equity
-8.0%
Return on assets
-9.8%
Return on invested capital
0.20x
Asset turnover
-CNY 27.1M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026